Day One Biopharmaceuticals, Inc.
DAWNDelisted- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001845337
Day One Biopharmaceuticals, Inc. was delisted in 2026; its insiders filed their last Form 4 on Apr 27, 2026; 208 institutions reported holding it in 13F filings for Q1 2026, worth $1.85B in total; Soros Fund Management was the only superinvestor holding it.
13F holders, Q2 2021
Institutional positions in Day One Biopharmaceuticals, Inc. as of Jun 30, 2021. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 33
- +33 vs. Q1 2021
- Shares held
- 17.7M
- +17.7M vs. Q1 2021
- Total value
- $401.1M
- +$401.1M vs. Q1 2021
- New holders
- 33
- 0 more added
- Sold out
- 0
- 0 more reduced
Compare with Q1 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting DAWN on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 1 | $3.55K |
| Q1 2026 | 208 | $1.85B |
| Q4 2025 | 184 | $758.9M |
| Q3 2025 | 173 | $603.9M |
| Q2 2025 | 174 | $562.2M |
| Q1 2025 | 184 | $747.2M |
| Q4 2024 | 164 | $1.19B |
| Q3 2024 | 166 | $1.28B |
| Q2 2024 | 157 | $1.03B |
| Q1 2024 | 148 | $1.21B |
| Q4 2023 | 139 | $1.12B |
| Q3 2023 | 130 | $951.5M |
| Q2 2023 | 140 | $941.0M |
| Q1 2023 | 126 | $938.2M |
| Q4 2022 | 109 | $1.30B |
| Q3 2022 | 93 | $1.21B |
| Q2 2022 | 87 | $1.06B |
| Q1 2022 | 66 | $429.6M |
| Q4 2021 | 58 | $707.6M |
| Q3 2021 | 45 | $452.9M |
| Q2 2021 | 33 | $418.3M |
| Q1 2021 | 0 | $0 |
Institutions, Q2 2021
Shares, value and share of portfolio for each institution holding Day One Biopharmaceuticals, Inc.; share changes are against Q1 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Ra Capital Management, L.P. | 4,965,588 | $113.1M | 1.81% | +4,965,588 | New |
| FMR LLC | 2,312,450 | $52.7M | 0.00% | +2,312,450 | New |
| Price T Rowe Associates Inc | 1,505,396 | $33.4M | 0.00% | +1,505,396 | New |
| Viking Global Investors LPSuperinvestorViking Global Investors | 1,341,396 | $30.5M | 0.09% | +1,341,396 | New |
| Janus Henderson Group PLC | 1,297,770 | $27.9M | 0.01% | +1,297,770 | New |
| Boxer Capital, LLC | 1,189,943 | $27.1M | 0.96% | +1,189,943 | New |
| BVF Inc | 918,975 | $20.9M | 0.78% | +918,975 | New |
| Deerfield Management Company, L.P. (Series C) | 818,980 | $18.6M | 0.33% | +818,980 | New |
| Perceptive Advisors LLC | 756,047 | $17.2M | 0.22% | +756,047 | New |
| Vanguard Group Inc | 619,384 | $14.1M | 0.00% | +619,384 | New |
| Franklin Resources Inc | 518,966 | $11.8M | 0.00% | +518,966 | New |
| Driehaus Capital Management LLC | 434,423 | $9.89M | 0.13% | +434,423 | New |
| Rock Springs Capital Management LP | 373,739 | $8.51M | 0.17% | +373,739 | New |
| Samsara BioCapital, LLC | 202,500 | $4.61M | 0.61% | +202,500 | New |
| HealthCor Management, L.P. | 103,717 | $2.36M | 0.10% | +103,717 | New |
| Alyeska Investment Group, L.P. | 103,200 | $2.35M | 0.03% | +103,200 | New |
| LMR Partners LLP | 50,000 | $1.14M | 0.02% | +50,000 | New |
| Marshall Wace North America L.P. | 41,147 | $937.0K | 0.00% | +41,147 | New |
| Logos Global Management LP | 37,069 | $844.0K | 0.07% | +37,069 | New |
| Geode Capital Management, LLC | 34,935 | $795.0K | 0.00% | +34,935 | New |
| Squarepoint Ops LLC | 18,927 | $431.0K | 0.00% | +18,927 | New |
| TD Asset Management Inc | 16,856 | $400.0K | 0.00% | +16,856 | New |
| Northern Trust Corp | 12,718 | $290.0K | 0.00% | +12,718 | New |
| Virtu Financial LLC | 12,497 | $285.0K | 0.03% | +12,497 | New |
| Goldman Sachs Group Inc | 11,594 | $264.0K | 0.00% | +11,594 | New |
| ExodusPoint Capital Management, LP | 9,372 | $213.0K | 0.00% | +9,372 | New |
| Maven Securities LTD | 9,000 | $210.0K | 0.02% | +9,000 | New |
| BlackRock Inc. | 4,372 | $99.0K | 0.00% | +4,372 | New |
| Morgan Stanley | 2,374 | $54.0K | 0.00% | +2,374 | New |
| Capital Analysts, LLC | 750 | $17.0K | 0.00% | +750 | New |
| Bank of America Corp | 700 | $16.0K | 0.00% | +700 | New |
| JPMorgan Chase & Co | 54 | $1.00K | 0.00% | +54 | New |
| Tower Research Capital LLC (TRC) | 10 | $0 | 0.00% | +10 | New |